Skip to main content

Articles

Page 64 of 90

  1. Patients with chronic kidney disease (CKD) are at high risk of progression to end stage renal disease and cardiovascular events. Physical activity may reduce these risks by improving metabolic health. We teste...

    Authors: Wilson Bowlby, Leila R. Zelnick, Connor Henry, Jonathan Himmelfarb, Steven E. Kahn, Bryan Kestenbaum, Cassianne Robinson-Cohen, Kristina M. Utzschneider and Ian H. de Boer
    Citation: BMC Nephrology 2016 17:187
  2. Chronic kidney disease (CKD) poses a major health threat to people living in low- and middle-income countries, especially when it is combined with HIV, antiretroviral treatment (ART) or communicable and non-co...

    Authors: Nicola Glaser, Sam Phiri, Tom Bruckner, Dominic Nsona, Hannock Tweya, Nomeda Ahrenshop and Florian Neuhann
    Citation: BMC Nephrology 2016 17:186
  3. The association between psoriasis and membranous nephropathy (MN) remains largely unclear. We examined the prevalence of serum PLA2R antibody and characterized the expression of PLA2R and THSD7A in glomeruli i...

    Authors: Yong-Chun Ge, Bo Jin, Cai-Hong Zeng, Ming-Chao Zhang, Da-Cheng Chen, Ru Yin and Wei-Bo Le
    Citation: BMC Nephrology 2016 17:185
  4. Patients with chronic kidney disease have a markedly increased cardiovascular mortality compared with the general population. Long chain n-3 polyunsaturated fatty acids have been suggested to possess cardioprotec...

    Authors: Morten Borg, My Svensson, Johan V. Povlsen, Erik B. Schmidt, Christian Aalkjær, Jeppe H. Christensen and Per Ivarsen
    Citation: BMC Nephrology 2016 17:184
  5. Aboriginal Australians are at high risk of cardiovascular, metabolic and renal diseases, resulting in a marked reduction in life expectancy when compared to the rest of the Australian population. This is partl...

    Authors: David L. Duffy, Stephen P. McDonald, Beverley Hayhurst, Sianna Panagiotopoulos, Trudy J. Smith, Xing L. Wang, David E. Wilcken, Natalia L. Duarte, John Mathews and Wendy E. Hoy
    Citation: BMC Nephrology 2016 17:183
  6. Despite the multiple benefits of maintaining residual urine volume (RUV) in hemodialysis (HD), there is limited data from Sub-Saharan Africa. The aim of this study was to assess the impact of RUV decline on th...

    Authors: Vieux Momeme Mokoli, Ernest Kiswaya Sumaili, François Bompeka Lepira, Jean Robert Rissassy Makulo, Justine Busanga Bukabau, Patrick Parmba osa Izeidi, Jeannine Losa Luse, Stéphane Kalambay Mukendi, Désiré Kulimba Mashinda and Nazaire Mangani Nseka
    Citation: BMC Nephrology 2016 17:182
  7. T-cell-mediated rejection (TCMR) remains a major cause of kidney allograft failure. The characterization of T-cell repertoire in different immunological disorders has emerged recently as a novel tool with sign...

    Authors: Houda Alachkar, Martin Mutonga, Taigo Kato, Sowjanya Kalluri, Yoichi Kakuta, Motohide Uemura, Ryoichi Imamura, Norio Nonomura, Vikas Vujjini, Sami Alasfar, Hamid Rabb, Yusuke Nakamura and Nada Alachkar
    Citation: BMC Nephrology 2016 17:181
  8. Patients with chronic kidney disease (CKD) have a high symptoms burden that is related to a poor health-related quality of life (HRQoL) and high costs of care. Validated instruments may be useful for assessing...

    Authors: Daniel Gutiérrez-Sánchez, Juan P. Leiva-Santos, Rosa Sánchez-Hernández, Domingo Hernández-Marrero and Antonio I. Cuesta-Vargas
    Citation: BMC Nephrology 2016 17:180
  9. Histone H3K4 trimethylation (H3K4 me3) is found in active euchromatic regions and plays an important role in podocyte function in which actin filaments are abundant in the foot processes. The pathogenesis of m...

    Authors: Takayuki Fujino and Naoyuki Hasebe
    Citation: BMC Nephrology 2016 17:179
  10. Oxidative stress is thought to be involved in the pathogenesis of microalbuminuria in Sickle cell anemia (SCA). Antioxidant enzymes such as glutathione peroxidase (GPx) and Cu-Zn superoxide dismutase (SOD) may...

    Authors: Karen E. Itokua, Jean Robert Makulo, François B. Lepira, Michel N. Aloni, Pépé M. Ekulu, Ernest K. Sumaili, Justine B. Bukabau, Vieux M. Mokoli, Augustin L. Longo, François M. Kajingulu, Chantal V. Zinga, Yannick M. Nlandu, Yannick M. Engole, Pierre Z. Akilimali, René M. Ngiyulu, Jean Lambert Gini…
    Citation: BMC Nephrology 2016 17:178
  11. Intravenous iron affects serum levels of intact fibroblast growth factor-23 (iFGF23) and its cleavage product c-terminal FGF23 (cFGF23) in iron-deficient people with normal renal function. We hypothesized that...

    Authors: Matthew A. Roberts, Louis Huang, Darren Lee, Robert MacGinley, Stefanie M. A. Troster, Annette B. Kent, Sukhvinder S. Bansal, Iain C. Macdougall and Lawrence P. McMahon
    Citation: BMC Nephrology 2016 17:177
  12. Sclerostin is a paracrine acting factor, which is expressed in the osteocytes and articular chondrocytes. Sclerostin decreases the osteoblast-related bone formation through the inhibition of the Wnt/β-catenin ...

    Authors: Piotr Kuczera, Marcin Adamczak and Andrzej Więcek
    Citation: BMC Nephrology 2016 17:176
  13. Granulocyte colony-stimulating factor (G-CSF) can induce regulatory T cells (Tregs) as well as myeloid-derived suppressor cells (MDSCs). Despite the immune modulatory effects of G-CSF, results of G-CSF treatme...

    Authors: Ji-Jing Yan, Enkthuya Jambaldorj, Jae-Ghi Lee, Joon Young Jang, Jung Min Shim, Miyeun Han, Tai Yeon Koo, Curie Ahn and Jaeseok Yang
    Citation: BMC Nephrology 2016 17:175
  14. Although chronic kidney disease (CKD) affects a growing number of people, epidemiologic data on incident CKD in the general population are scarce. Screening strategies to increase early CKD detection have been...

    Authors: Carole Ayav, Jean-Baptiste Beuscart, Serge Briançon, Alain Duhamel, Luc Frimat and Michèle Kessler
    Citation: BMC Nephrology 2016 17:174
  15. High rates of volume overload hospitalizations may indicate inadequate dialysis facility fluid management. Administrative claims databases are often used to study such outcomes, but these data are generated fo...

    Authors: Magdalene M. Assimon, Thuy Nguyen, Suzanne L. Katsanos, Steven M. Brunelli and Jennifer E. Flythe
    Citation: BMC Nephrology 2016 17:173
  16. Obesity is a risk factor for end-stage renal disease. Renal hyperfiltration, defined as an abnormally high glomerular filtration rate (GFR), is a link in the causal chain between diabetes and chronic kidney di...

    Authors: Vidar Tor Nyborg Stefansson, Jørgen Schei, Trond Geir Jenssen, Toralf Melsom and Bjørn Odvar Eriksen
    Citation: BMC Nephrology 2016 17:172
  17. Adults with chronic kidney disease (CKD) exhibit alterations in tryptophan metabolism, mainly via the kynurenine pathway, due to higher enzymatic activity induced mainly by inflammation. Indoles produced by gu...

    Authors: Naama Karu, Charlotte McKercher, David S. Nichols, Noel Davies, Robert A. Shellie, Emily F. Hilder and Matthew D. Jose
    Citation: BMC Nephrology 2016 17:171
  18. The purpose of this study was to investigate the usefulness of intracystic MRI features for detection of severe cyst infection that is usually refractory to antibiotic therapy alone in patients with autosomal ...

    Authors: Tatsuya Suwabe, Yoshifumi Ubara, Toshiharu Ueno, Noriko Hayami, Junichi Hoshino, Aya Imafuku, Masahiro Kawada, Rikako Hiramatsu, Eiko Hasegawa, Naoki Sawa, Satoshi Saitoh, Itsuko Okuda and Kenmei Takaichi
    Citation: BMC Nephrology 2016 17:170
  19. Experimental studies have linked peritubular capillary (PTC) loss with progression of chronic kidney disease. Minimal information on PTC in lupus nephritis (LN) has been reported. We therefore evaluated the PT...

    Authors: Sirirat Anutrakulchai, Tanin Titipungul, Thanyaluk Pattay, Putachart Mesung, Anucha Puapairoj, Dhavee Sirivongs, Cholatip Pongsakul, Prasit Futrakul, Bandit Thinkhamrop and Richard J. Johnson
    Citation: BMC Nephrology 2016 17:169
  20. Measurement of albuminuria to stratify risk in chronic kidney disease (CKD) is not done universally in the primary care setting despite recommendation in KDIGO (Kidney Disease Improving Global Outcomes) guidel...

    Authors: Alex R. Chang, Michael Evans, Christina Yule, Larissa Bohn, Amanda Young, Meredith Lewis, Elisabeth Graboski, Bethany Gerdy, William Ehmann, Jonathan Brady, Leah Lawrence, Natacha Antunes, Jamie Green, Susan Snyder, H. Lester Kirchner, Morgan Grams…
    Citation: BMC Nephrology 2016 17:168
  21. Despite the use of low-osmolar contrast media that have significantly reduced the occurrence of severe adverse reactions, contrast-induced (CI) acute kidney injury (AKI) remains the third cause of AKI in hospi...

    Authors: Pierre Aubry, Georges Brillet, Laura Catella, Aurélie Schmidt and Stève Bénard
    Citation: BMC Nephrology 2016 17:167
  22. Patients receiving hemodialysis with values outside of target levels for parathyroid hormone (PTH: 150–600 pg/mL), calcium (Ca: 8.4–10.2 mg/dL), and phosphate (P: 3.5–5.5 mg/dL) are at elevated morbidity and m...

    Authors: Geoffrey A. Block, Akeem A. Yusuf, Mark D. Danese, Heidi S. Wirtz, Yan Hu, Thy P. Do, Kerry Cooper, David T. Gilbertson, Brian D. Bradbury and Allan J. Collins
    Citation: BMC Nephrology 2016 17:166
  23. End-Stage Renal disease (ESRD) is associated with increased morbidity and mortality. We assessed the occurrence, time-trend and determinants of fatal outcomes of haemodialysis-treated ESRD patients over a 10-y...

    Authors: Marie Patrice Halle, Gloria Ashuntantang, Francois Folefack Kaze, Christian Takongue and Andre-Pascal Kengne
    Citation: BMC Nephrology 2016 17:165
  24. Experimental studies showed that 25-hydroxy-vitamin D [25(OH)D] deficiency (defined as 25-hydroxy-vitamin D < 15 ng/ml) has been associated with CKD progression. Patients with IgA nephropathy have an exception...

    Authors: Xiao-Hua Li, Xin-Ping Huang, Ling Pan, Cheng-Yu Wang, Ju Qin, Feng-Wei Nong, Yu-Zhen Luo, Yue Wu, Yu-Ming Huang, Xi Peng, Zhen-Hua Yang and Yun-Hua Liao
    Citation: BMC Nephrology 2016 17:164
  25. The ISAR study is a prospective, longitudinal, observational cohort study to improve the cardiovascular risk stratification in endstage renal disease (ESRD). The major goal is to characterize the cardiovascula...

    Authors: Christoph Schmaderer, Susanne Tholen, Anna-Lena Hasenau, Christine Hauser, Yana Suttmann, Siegfried Wassertheurer, Christopher C. Mayer, Axel Bauer, Kostantinos D. Rizas, Stephan Kemmner, Konstantin Kotliar, Bernhard Haller, Johannes Mann, Lutz Renders, Uwe Heemann and Marcus Baumann
    Citation: BMC Nephrology 2016 17:161
  26. Endothelial dysfunction is an important precursor to the development of atherosclerosis, and has been suggested to play a role in the increased cardiovascular risk in patients with end stage renal disease. End...

    Authors: Clark Kensinger, Aihua Bian, Meagan Fairchild, Guanhua Chen, Loren Lipworth, T. Alp Ikizler and Kelly A. Birdwell
    Citation: BMC Nephrology 2016 17:160
  27. The true cause of death in severe hyponatraemic patients remains controversial. The present study aimed to analyse the relationship between comorbidity, medical management and prognosis in severe hyponatraemic...

    Authors: Thierry Krummel, Eric Prinz, Marie-Astrid Metten, Claire Borni-Duval, Dorothée Bazin-Kara, Emmanuelle Charlin, Jean-Marc Lessinger and Thierry Hannedouche
    Citation: BMC Nephrology 2016 17:159
  28. Correction of metabolic acidosis (MA) with nutritional therapy or bicarbonate administration is widely used in chronic kidney disease (CKD) patients. However, it is unknown whether these interventions reduce i...

    Authors: Antonio Bellasi, Lucia Di Micco, Domenico Santoro, Stefania Marzocco, Emanuele De Simone, Mario Cozzolino, Luca Di Lullo, Pasquale Guastaferro and Biagio Di Iorio
    Citation: BMC Nephrology 2016 17:158
  29. Patients with end stage renal disease (ESRD), including stage 5 chronic kidney disease (CKD), hemodialysis (HD) and peritoneal dialysis (PD), are at high risk for stroke-related morbidity, mortality and bleedi...

    Authors: Jingwen Tan, Shuiqing Liu, Jodi B. Segal, G. Caleb Alexander and Mara McAdams-DeMarco
    Citation: BMC Nephrology 2016 17:157
  30. Patients with chronic kidney disease (CKD) commonly have unmet information needs. Greater patient participation in healthcare discussions can address these needs and improve health outcomes. We developed a pat...

    Authors: Swati Lederer, Michael J. Fischer, Howard S. Gordon, Anuradha Wadhwa, Subhash Popli and Elisa J. Gordon
    Citation: BMC Nephrology 2016 17:155
  31. It is known that continuous venonenous hemofiltration (CVVH) does not affect the plasma level of neutrophil gelatinase-associated lipocalin (pNGAL) in acute kidney injury (AKI) patients. However, because of th...

    Authors: Xingui Dai, Tao Li, Zhenhua Zeng, Chunlai Fu, Shengbiao Wang, Yeping Cai and Zhongqing Chen
    Citation: BMC Nephrology 2016 17:154
  32. Observational studies have recently associated a decrease in serum parathyroid hormone (PTH) level with a higher rate of mortality among hemodialysis (HD) patients. Decreases in PTH level can result from medic...

    Authors: Guillaume Jean, Jean-Claude Souberbielle, Eric Zaoui, Christie Lorriaux, Jean-Marc Hurot, Brice Mayor, Patrik Deleaval, Manolie Mehdi and Charles Chazot
    Citation: BMC Nephrology 2016 17:153
  33. Whether polyunsaturated fatty acids (PUFA) are associated with end-stage renal disease (ESRD) in populations with a high burden of risk factors for kidney disease is unknown. We sought to determine whether PUF...

    Authors: Rakesh Malhotra, Kerri L. Cavanaugh, William J. Blot, T. Alp Ikizler, Loren Lipworth and Edmond K. Kabagambe
    Citation: BMC Nephrology 2016 17:152
  34. Epidemiological studies have shown an inverse relationship between vitamin D levels and cardiovascular diseases. However, this does not infer a causal relationship between the two. Chronic kidney disease (CKD)...

    Authors: Yong-Muh Ng, Soo-Kun Lim, Pei-San Kang, Khairul Azmi Abdul Kadir and Mei-Ling Sharon Tai
    Citation: BMC Nephrology 2016 17:151
  35. Researchers have developed several equations to predict glomerular filtration rate (GFR) in patients with chronic kidney diseases (CKD). However, there are scarcely any studies performed to discern the best eq...

    Authors: Meixue Chen, Jumei Xia, Guangchang Pei, Ying Zhang, Shuting Wu, Yushuang Qin, Yuanjun Deng, Shuiming Guo, Yanyan Guo, Gang Xu and Min Han
    Citation: BMC Nephrology 2016 17:150
  36. Higher incidence of malignancy and infectious diseases in kidney transplant recipients is related to immunosuppressive treatment after transplantation and the recipient’s native immune system. The complement s...

    Authors: Julia Smedbråten, Geir Mjøen, Anders Hartmann, Anders Åsberg, Halvor Rollag, Tom Eirik Mollnes, Leiv Sandvik, Morten W. Fagerland, Steffen Thiel and Solbjørg Sagedal
    Citation: BMC Nephrology 2016 17:148
  37. Mortality in patients with end-stage renal disorders is often a consequence of cardiovascular complications. Renal replacement therapies may contribute to this morbidity by promoting cellular activation. In re...

    Authors: Gergely Becs, Renáta Hudák, Zsolt Fejes, Ildikó Beke Debreceni, Harjit Pal Bhattoa, József Balla and János Kappelmayer
    Citation: BMC Nephrology 2016 17:147
  38. Several shared common gene networks participate in development of interstinal ganglia and also nephron formation; the glial cell line-derived neurotrophic factor/Ret/glial cell line-derived neurotrophic factor...

    Authors: Keisuke Sugimoto, Tomoki Miyazawa, Hitomi Nishi, Kohei Miyazaki, Takuji Enya, Mitsuru Okada and Tsukasa Takemura
    Citation: BMC Nephrology 2016 17:146
  39. The current standard for induction phase treatment of lupus nephritis is steroid combined with mycophenolate mofetil or pulse intravenous cyclophosphamide (IVC). The lowest dose of IVC recommended for inductio...

    Authors: Mahesh R. Sigdel, Mukunda P. Kafle and Dibya Singh Shah
    Citation: BMC Nephrology 2016 17:145
  40. Vitamin D (25-hydroxyvitamin D; 25[OH]D) deficiency (VDD) is highly prevalent in chronic kidney disease. The aim of this study was to evaluate the effect of oral ergocalciferol supplementation on requirement o...

    Authors: Gaurav Agarwal, Padam Hirachan, Jonathan Gelfond, Paolo Fanti, Claudia Hura and Shweta Bansal
    Citation: BMC Nephrology 2016 17:144
  41. Cardiovascular disease (CVD) is often comorbid with chronic kidney disease (CKD). Small low-density lipoprotein cholesterol (sdLDL-C) has also been found to increase risk for CVD. The goal of the present study...

    Authors: Hao Shen, Yan Xu, Jingfen Lu, Chunfang Ma, Yadong Zhou, Qiong Li, Xu Chen, Ao Zhu and Guorong Shen
    Citation: BMC Nephrology 2016 17:143
  42. To investigate the combined use of intravoxel incoherent motion (IVIM) diffusion-weighted (DW) and blood oxygen level dependent (BOLD) magnetic resonance imaging (MRI) to assess rat renal function using a 1.5T...

    Authors: Neil P. Jerome, Jessica K. R. Boult, Matthew R. Orton, James d’Arcy, David J. Collins, Martin O. Leach, Dow-Mu Koh and Simon P. Robinson
    Citation: BMC Nephrology 2016 17:142
  43. The orally administered spherical carbon adsorbent AST-120 is used on-label in Asian countries to slow renal disease progression in patients with progressive chronic kidney disease (CKD). Recently, two multina...

    Authors: Gerald Schulman, Tomas Berl, Gerald J. Beck, Giuseppe Remuzzi, Eberhard Ritz, Miho Shimizu, Yuko Shobu and Mami Kikuchi
    Citation: BMC Nephrology 2016 17:141
  44. Immunotactoid glomerulopathy (ITG) is a rare cause of proteinuria characterized by organized microtubular deposits in the glomerulus. ITG has been associated with underlying lymphoproliferative disorders and a...

    Authors: Aditi Khandelwal, Martina A. Trinkaus, Hassan Ghaffar, Serge Jothy and Marc B. Goldstein
    Citation: BMC Nephrology 2016 17:140
  45. Diabetic nephropathy is the leading cause of end stage kidney disease worldwide. The pathogenesis of this disease remains elusive and multiple factors have been implicated. These include the effects of hypergl...

    Authors: Rosa M. Montero, Gurjeet Bhangal, Charles D. Pusey, Andrew H. Frankel and Frederick W. K. Tam
    Citation: BMC Nephrology 2016 17:139

Affiliated with

Annual Journal Metrics

  • 2022 Citation Impact
    2.3 - 2-year Impact Factor
    2.8 - 5-year Impact Factor
    1.064 - SNIP (Source Normalized Impact per Paper)
    0.746 - SJR (SCImago Journal Rank)

    2023 Speed
    28 days submission to first editorial decision for all manuscripts (Median)
    158 days submission to accept (Median)

    2023 Usage 
    3,053,628 downloads
    3,742 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal